BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 9217057)

  • 1. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
    Fong SE; Greenwood JD; Williamson JC; Derse D; Pallansch LA; Copeland T; Rasmussen L; Mentzer A; Nagashima K; Tobin G; Gonda MA
    Virology; 1997 Jul; 233(2):339-57. PubMed ID: 9217057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bovine immunodeficiency virus: cloning of a tat/rev cDNA encoding a novel Tat protein with enhanced transactivation activity.
    St-Louis MC; Abed Y; Archambault D
    Arch Virol; 2005 Aug; 150(8):1529-47. PubMed ID: 15821973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cis-acting regulatory elements in the bovine immunodeficiency virus long terminal repeat.
    Fong SE; Pallansch LA; Mikovits JA; Lackman-Smith CS; Ruscetti FW; Gonda MA
    Virology; 1995 Jun; 209(2):604-14. PubMed ID: 7778292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and viral specificity of equine infectious anemia virus Tat transactivation.
    Maury WJ; Carpenter S; Graves K; Chesebro B
    Virology; 1994 May; 200(2):632-42. PubMed ID: 8178449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trans-dominant Tat mutants with alterations in the basic domain inhibit HIV-1 gene expression.
    Modesti N; Garcia J; Debouck C; Peterlin M; Gaynor R
    New Biol; 1991 Aug; 3(8):759-68. PubMed ID: 1931822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second exon of Tat of HIV-2 is required for optimal trans-activation of HIV-1 and HIV-2 LTRs.
    Tong-Starksen SE; Baur A; Lu XB; Peck E; Peterlin BM
    Virology; 1993 Aug; 195(2):826-30. PubMed ID: 8337847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Construction and analysis of activity of an HIV-1/bovine immunodeficiency virus chimeric clone cDNA].
    Yang YS; Chen GM; Dong WP; Chen QM; Geng YQ; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):143-5. PubMed ID: 12869996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transactivation is a conserved function among primate lentivirus Vpr proteins but is not shared by Vpx.
    Philippon V; Matsuda Z; Essex M
    J Hum Virol; 1999; 2(3):167-74. PubMed ID: 10413368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAR-independent activation of HIV-1 requires the activation domain but not the RNA-binding domain of Tat.
    Taylor JP; Kundu M; Khalili K
    Virology; 1993 Aug; 195(2):780-5. PubMed ID: 8337844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tat-regulated production of multimerized TAR RNA inhibits HIV-1 gene expression.
    Lisziewicz J; Rappaport J; Dhar R
    New Biol; 1991 Jan; 3(1):82-9. PubMed ID: 2039768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bovine immunodeficiency-like virus encodes factors which trans activate the long terminal repeat.
    Pallansch LA; Lackman-Smith CS; Gonda MA
    J Virol; 1992 May; 66(5):2647-52. PubMed ID: 1313891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altering the context of an RNA bulge switches the binding specificities of two viral Tat proteins.
    Smith CA; Crotty S; Harada Y; Frankel AD
    Biochemistry; 1998 Jul; 37(30):10808-14. PubMed ID: 9692971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design of a dimeric RNA-peptide complex.
    Campisi DM; Calabro V; Frankel AD
    EMBO J; 2001 Jan; 20(1-2):178-86. PubMed ID: 11226168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
    Kashanchi F; Sadaie MR; Brady JN
    Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
    Robinson D; Elliott JF; Chang LJ
    Gene Ther; 1995 Jun; 2(4):269-78. PubMed ID: 7552987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and expression of the equine infectious anemia virus transcriptional trans-activator (tat).
    Derse D; Dorn P; DaSilva L; Martarano L
    Dev Biol Stand; 1990; 72():39-48. PubMed ID: 2178129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bovine immunodeficiency virus: identification of a long terminal repeat sequence with enhanced promoter activity.
    Cojocariu M; St-Louis MC; Archambault D
    Arch Virol; 2009; 154(7):1163-7. PubMed ID: 19547911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.
    Desfosses Y; Solis M; Sun Q; Grandvaux N; Van Lint C; Burny A; Gatignol A; Wainberg MA; Lin R; Hiscott J
    J Virol; 2005 Jul; 79(14):9180-91. PubMed ID: 15994812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B.
    Negrini M; Rimessi P; Sabbioni S; Caputo A; Balboni PG; Gualandri R; Manservigi R; Grossi MP; Barbanti-Brodano G
    Biotechniques; 1991 Mar; 10(3):344-53. PubMed ID: 1829615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.